Study of Nitazoxanide, Peginterferon Alfa-2a and Ribavirin in Treatment-Naive Hepatitis C Patients
Status:
Completed
Trial end date:
2010-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if nitazoxanide in combination with peginterferon
alfa-2a and ribavirin is safe and effective in treating chronic hepatitis C in
treatment-naive patients.